News

BioMelbourne Network Policy Principles – 2018 State Election

May 2018 The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now…

AusBiotech announces leadership changes

Mr Glenn Cross retires as AusBiotech’s CEO, and Ms Lorraine Chiroiu appointed as new CEO effective early July 2018 Mr Glenn Cross retirement AusBiotech Chairman, Julie Phillips, has tonight announced that Mr Glenn Cross has decided to retire…

Bioforum Data Focused CRO Opens New Melbourne Office

Company provides local services for companies running R&D activities in Australia Bioforum – the Data Focused CRO and the leading Medidata partner in Israel, servicing research and academic institutes, pharma companies, CROs and startups locally and globally for…

$10m in funding awarded to 11 projects to boost health innovation

MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and the Minister for Health, the Hon Greg Hunt MP, today announced the first 11 recipients of $10 million investment from the Australian…

Prota Therapeutics partners with world-leading bioscience company, Chr. Hansen

Prota Therapeutics partners with leading global bioscience company, Chr. Hansen, to progress the development of oral immunotherapies to treat food allergies. The partnership will assess the world’s best documented probiotic strain LGG® in a Phase III clinical trial…

Future Plans Announced for Digital Health CRC

A $200+ million opportunity to transform health delivery: improving health outcomes; reducing waste in the health system; building businesses and jobs. The new Digital Health CRC (Cooperative Research Centre) will invest over $200 million to develop and test…

Cancer Therapeutics CRC Appoints New CEO

Cancer Therapeutics CRC (CTX), a small molecule oncology drug discovery and development group partnered with some of Australia’s pre-eminent medical research institutions, is pleased to announce the appointment of Brett Carter as Chief Executive Officer. Brett will succeed…

Immutep Raises A$6.85M Through Institutional Placement

Read ASX Announcement Here • A$6.85m raised through share institutional placement to drive immuno-oncology development programs • Placement of new ordinary shares to leading Australian healthcare institutional investors Platinum Asset Management and Australian Ethical Investment, U.S. healthcare institutional…

Immutep Enters Into Clinical Trial Collaboration and Supply Agreement with MSD

Read ASX Announcement Here Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as…

Event Summary – Clinical Trials in Victoria: Building global competitive advantage

Summary by Millie Dwyer, Student Intern This BioMelbourne Network BioBreakfast event hosted at St Vincent’s launched the Victorian Clinical Trials Gateway and discussed Victoria’s clinical trial landscape. The event explored Victoria’s strengths and weaknesses in this field, inspiring…

New report aims to broaden understanding of how new medicines are funded in Australia

– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…

QuickFire Challenge fuels medical innovation

The Victorian Government in collaboration with Johnson & Johnson Innovation JLABS today announced the Victorian QuickFire Challenge, a competition giving healthcare entrepreneurs the chance to transform their ground-breaking research into the products that will advance the well-being of people around…

Home

News & opinion

Member Directory

Events